Chronic obstructive pulmonary disease: NHLBI workshop on the primary prevention of chronic lung diseases

Annals of the American Thoracic Society

Volumn 11, Issue SUPPL. 3, 2014, Pages

  Drummond, M Bradley ^a   Buist, A Sonia ^b   Crapo, James D ^c   Wise, Robert A ^a   Rennard, Stephen I ^d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c DEPARTMENT OF MEDICINE   (United States)

^d UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Chronic obstructive pulmonary disease; Primary prevention

Indexed keywords

ACETYLCYSTEINE; ALPHA 1 ANTITRYPSIN; BIOLOGICAL MARKER; CIGARETTE SMOKE; CORTICOSTEROID; MUSCARINIC RECEPTOR BLOCKING AGENT; TRACE ELEMENT;

ALPHA 1 ANTITRYPSIN DEFICIENCY; CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DISEASE COURSE; EMPHYSEMA; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENETIC DIFFERENCE; GENETIC TRAIT; HUMAN; LUNG ALVEOLUS WALL; LUNG DEVELOPMENT; LUNG FUNCTION; MEDICAL RESEARCH; PHENOTYPE; PRIMARY PREVENTION; PULMONARY HYPERTENSION; RISK FACTOR; SCREENING; SMOKING; SMOKING CESSATION; SPIROMETRY; WORKSHOP; NATIONAL HEALTH ORGANIZATION; ORGANIZATION; PROCEDURES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; UNITED STATES;

CONGRESSES AS TOPIC; HUMANS; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE (U.S.); PRIMARY PREVENTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; UNITED STATES;

EID: 84899097221     PISSN: 23256621     EISSN: None     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201312-432LD     Document Type: Conference Paper

References (35)

1. Kochanek KD, Xu J, Murphy SL, Minino AM, Kung H. Deaths: preliminary data for 2009. Natl Vital Stat Rep 2011;59:1-51.
2. From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). [Internet]. 2011. [updated 2014 Jan 1; accessed 2014 Jan 8]. Available from: http://www.goldcopd.org/
3. Vollmer WM, Gíslason T, Burney P, Enright PL, Gulsvik A, Kocabas A, Buist AS. Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study. Eur Respir J 2009;34:588-597.
4. 1 to FVC as a basis for establishing chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010;181:446-451.
5. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, et al. Interpretative strategies for lung function tests. Eur Respir J 2005;26:948-968. (Pubitemid 41632054)
6. Pellegrino R, Brusasco V, Viegi G, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, et al. Definition of COPD: based on evidence or opinion? Eur Respir J 2008;31:681-682.
7. 1/FVC < 0.70 in diagnosing COPD: an evidence-based review. Respir Med 2011;105:907-915.
8. Mannino DM. Defining chronic obstructive pulmonary disease...and the elephant in the room. Eur Respir J 2007;30:189-190. (Pubitemid 47194169)
9. Mannino DM, Sonia Buist A, Vollmer WM. Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function? Thorax 2007;62:237-241. (Pubitemid 46579804)
10. Nakano Y, Muro S, Sakai H, Hirai T, Chin K, Tsukino M, Nishimura K, Itoh H, Paré PD, Hogg JC, et al. Computed tomographic measurements of airway dimensions and emphysema in smokers: correlation with lung function. Am J Respir Crit Care Med 2000;162:1102-1108.
11. de Jong PA, Müller NL, Paré PD, Coxson HO. Computed tomographic imaging of the airways: relationship to structure and function. Eur Respir J 2005;26:140-152. (Pubitemid 40945943)
12. Washko GR, Criner GJ, Mohsenifar Z, Sciurba FC, Sharafkhaneh A, Make BJ, Hoffman EA, Reilly JJ. Computed tomographic-based quantification of emphysema and correlation to pulmonary function and mechanics. COPD 2008;5:177-186. (Pubitemid 351892733)
13. 1: the Lung Health Study. JAMA 1994;272:1497-1505.
14. Barnes PJ. Chronic obstructive pulmonary disease. N Engl J Med 2000;343:269-280. (Pubitemid 30490396)
15. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004;350:2645-2653. (Pubitemid 38787999)
16. Snoeck-Stroband JB, Lapperre TS, Gosman MM, Boezen HM, Timens W, ten Hacken NH, Sont JK, Sterk PJ, Hiemstra PS; Groningen Leiden Universities Corticosteroids in Obstructive Lung Disease (GLUCOLD) Study Group. Chronic bronchitis sub-phenotype within COPD: inflammation in sputum and biopsies. Eur Respir J 2008;31:70-77.
17. Saetta M, Turato G, Maestrelli P, Mapp CE, Fabbri LM. Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;163:1304-1309. (Pubitemid 32506590)
18. Tuder RM, Petrache I, Elias JA, Voelkel NF, Henson PM. Apoptosis and emphysema: the missing link. Am J Respir Cell Mol Biol 2003;28:551-554. (Pubitemid 36543401)
19. Barnes PJ. Mediators of chronic obstructive pulmonary disease. Pharmacol Rev 2004;56:515-548. (Pubitemid 39658462)
20. Spurzem JR, Rennard SI. Pathogenesis of COPD. Semin Respir Crit Care Med 2005;26:142-153. (Pubitemid 40617293)
21. Barnes PJ. The cytokine network in asthma and chronic obstructive pulmonary disease. J Clin Invest 2008;118:3546-3556.
22. Karadag F, Karul AB, Cildag O, Yilmaz M, Ozcan H. Biomarkers of systemic inflammation in stable and exacerbation phases of COPD. Lung 2008;186:403-409.
23. Adair-Kirk TL, Atkinson JJ, Senior RM. Smoke particulates stress lung cells. Nat Med 2008;14:1024-1025.
24. + T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:822-826.
25. Kuschner WG, D'Alessandro A, Wong H, Blanc PD. Dose-dependent cigarette smoking-related inflammatory responses in healthy adults. Eur Respir J 1996;9:1989-1994. (Pubitemid 26333532)
26. Tappia PS, Troughton KL, Langley-Evans SC, Grimble RF. Cigarette smoking influences cytokine production and antioxidant defences. Clin Sci (Lond) 1995;88:485-489.
27. Keatings VM, Collins PD, Scott DM, Barnes PJ. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996;153:530-534.
28. Checkley W, West KP Jr, Wise RA, Baldwin MR, Wu L, LeClerq SC, Christian P, Katz J, Tielsch JM, Khatry S, et al. Maternal vitamin A supplementation and lung function in offspring. N Engl J Med 2010;362:1784-1794.
29. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, Menezes AM, Sullivan SD, Lee TA, Weiss KB, et al.; BOLD Collaborative Research Group. International variation in the prevalence of COPD (the BOLD study): a population-based prevalence study. Lancet 2007;370:741-750. (Pubitemid 47321907)
30. Drummond MB, Merlo CA, Astemborski J, Marshall MM, Kisalu A, McDyer JF, Mehta SH, Brown RH, Wise RA, Kirk GD. The effect of HIV infection on longitudinal lung function decline among injection drug users: a prospective cohort. AIDS 2013;27:1303-1311.
31. Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med 2008;359:2355-2365.
32. American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med 2003;168:818-900.
33. Burrows B. An overview of obstructive lung diseases. Med Clin North Am 1981;65:455-471. (Pubitemid 11048772)
34. Vestbo J, Edwards LD, Scanlon PD, Yates JC, Agusti A, Bakke P, Calverley PM, Celli B, Coxson HO, Crim C, et al.; ECLIPSE Investigators. Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med 2011;365:1184-1192.
35. Fletcher C, Peto R. The natural history of chronic airflow obstruction. BMJ 1977;1:1645-1648. (Pubitemid 8124466)